These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

463 related articles for article (PubMed ID: 35890268)

  • 1. Nanomaterial-Based Drug Delivery System Targeting Lymph Nodes.
    Cheng Z; Que H; Chen L; Sun Q; Wei X
    Pharmaceutics; 2022 Jun; 14(7):. PubMed ID: 35890268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. State-of-the-art drug delivery system to target the lymphatics.
    Khaire OT; Mhaske A; Prasad AG; Almalki WH; Srivastava N; Kesharwani P; Shukla R
    J Drug Target; 2024 Apr; 32(4):347-364. PubMed ID: 38253594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multifunctional nanocarriers for targeted drug delivery and diagnostic applications of lymph nodes metastasis: a review of recent trends and future perspectives.
    Lan HR; Zhang YN; Han YJ; Yao SY; Yang MX; Xu XG; Mou XZ; Jin KT
    J Nanobiotechnology; 2023 Aug; 21(1):247. PubMed ID: 37528366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different leukocyte subsets are targeted by systemic and locoregional administration despite conserved nanomaterial characteristics optimal for lymph node delivery.
    Archer PA; Heiler AJ; Bourque AR; Alapan Y; Thomas SN
    Biomater Sci; 2024 Oct; 12(21):5582-5597. PubMed ID: 39318195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of false-negative metastatic lymph nodes by a lymphatic drug delivery system with 5-fluorouracil.
    Fujii H; Horie S; Sukhbaatar A; Mishra R; Sakamoto M; Mori S; Kodama T
    Cancer Med; 2019 May; 8(5):2241-2251. PubMed ID: 30945479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic Targeting of Lymph Node Metastasis through the Blood Vascular System by Using Size-Controlled Nanocarriers.
    Cabral H; Makino J; Matsumoto Y; Mi P; Wu H; Nomoto T; Toh K; Yamada N; Higuchi Y; Konishi S; Kano MR; Nishihara H; Miura Y; Nishiyama N; Kataoka K
    ACS Nano; 2015 May; 9(5):4957-67. PubMed ID: 25880444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor Regulation of Lymph Node Lymphatic Sinus Growth and Lymph Flow in Mice and in Humans.
    Habenicht LM; Kirschbaum SB; Furuya M; Harrell MI; Ruddell A
    Yale J Biol Med; 2017 Sep; 90(3):403-415. PubMed ID: 28955180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitation of lymphatic transport mechanism and barrier influences on lymph node-resident leukocyte access to lymph-borne macromolecules and drug delivery systems.
    Archer PA; Sestito LF; Manspeaker MP; O'Melia MJ; Rohner NA; Schudel A; Mei Y; Thomas SN
    Drug Deliv Transl Res; 2021 Dec; 11(6):2328-2343. PubMed ID: 34165731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor-Associated Macrophages Extend Along Lymphatic Flow in the Pre-metastatic Lymph Nodes of Human Gastric Cancer.
    Go Y; Tanaka H; Tokumoto M; Sakurai K; Toyokawa T; Kubo N; Muguruma K; Maeda K; Ohira M; Hirakawa K
    Ann Surg Oncol; 2016 Feb; 23 Suppl 2():S230-5. PubMed ID: 25743331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Novel Self-Assembly Nanocrystal as Lymph Node-Targeting Delivery System: Higher Activity of Lymph Node Targeting and Longer Efficacy Against Lymphatic Metastasis.
    Mao Y; Liu J; Shi T; Chen G; Wang S
    AAPS PharmSciTech; 2019 Aug; 20(7):292. PubMed ID: 31428888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radionuclide-guided sentinel lymph node mapping in urachal cancer.
    Połom W; Cytawa W; Połom A; Szurowska E; Lass P; Matuszewski M
    Adv Clin Exp Med; 2021 Feb; 30(2):203-210. PubMed ID: 33650332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Superselective Drug Delivery Using Doxorubicin-Encapsulated Liposomes and Ultrasound in a Mouse Model of Lung Metastasis Activation.
    Ouchi T; Sukhbaatar A; Horie S; Sakamoto M; Shiga K; Mori S; Kodama T
    Ultrasound Med Biol; 2018 Aug; 44(8):1818-1827. PubMed ID: 29793853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel targeted multifunctional nanoplatform for visual chemo-hyperthermia synergy therapy on metastatic lymph nodes via lymphatic delivery.
    Liu W; Ye X; He L; Cheng J; Luo W; Zheng M; Hu Y; Zhang W; Cao Y; Ran H; Yang L
    J Nanobiotechnology; 2021 Dec; 19(1):432. PubMed ID: 34930301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive Value of the Number of Harvested Lymph Nodes and Cut-Off for Lymph Node Ratio in the Prognosis of Stage II and III Colorectal Cancer Patients.
    Li Destri G; Barchitta M; Pesce A; Latteri S; Bosco D; Di Cataldo A; Agodi A; Puleo S
    J Invest Surg; 2019 Jan; 32(1):1-7. PubMed ID: 28972442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delivery of molecules to the lymph node via lymphatic vessels using ultrasound and nano/microbubbles.
    Kato S; Shirai Y; Kanzaki H; Sakamoto M; Mori S; Kodama T
    Ultrasound Med Biol; 2015 May; 41(5):1411-21. PubMed ID: 25637527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differing risk of cancer death among patients with lymph node metastasis after radical prostatectomy and pelvic lymph node dissection: identification of risk categories according to number of positive nodes and Gleason score.
    Schiavina R; Borghesi M; Brunocilla E; Manferrari F; Fiorentino M; Vagnoni V; Baccos A; Pultrone CV; Rocca GC; Rizzi S; Martorana G
    BJU Int; 2013 Jun; 111(8):1237-44. PubMed ID: 23331345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of Lymph Node Metastases by Ultra-pH-Sensitive Polymeric Nanoparticles.
    Bennett ZT; Feng Q; Bishop JA; Huang G; Sumer BD; Gao J
    Theranostics; 2020; 10(7):3340-3350. PubMed ID: 32194872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of negative lymph nodes in the survival outcomes of pN+ patients following radical gastrectomy: the inverse lymph node ratio as a better score to study negative lymph nodes.
    da Costa PM; Lages P; Onofre S; Ribeiro RM
    Updates Surg; 2020 Dec; 72(4):1031-1040. PubMed ID: 32388806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Number of Metastatic Lymph Nodes and Ratio of Metastatic Lymph Nodes to Total Number of Retrieved Lymph Nodes Are Risk Factors for Recurrence in Patients With Clinically Node Negative Papillary Thyroid Carcinoma.
    Zheng CM; Ji YB; Song CM; Ge MH; Tae K
    Clin Exp Otorhinolaryngol; 2018 Mar; 11(1):58-64. PubMed ID: 29032663
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 24.